LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Low HDL and high triglycerides predict COVID-19 severity.

    Masana, Lluís / Correig, Eudald / Ibarretxe, Daiana / Anoro, Eva / Arroyo, Juan Antonio / Jericó, Carlos / Guerrero, Carolina / Miret, Marcel la / Näf, Silvia / Pardo, Anna / Perea, Verónica / Pérez-Bernalte, Rosa / Plana, Núria / Ramírez-Montesinos, Rafael / Royuela, Meritxell / Soler, Cristina / Urquizu-Padilla, Maria / Zamora, Alberto / Pedro-Botet, Juan

    Scientific reports

    2021  Volume 11, Issue 1, Page(s) 7217

    Abstract: ... the infection was strongly and independently associated with a worse COVID-19 infection prognosis. The low HDL ... to predict the COVID-19 prognosis (severe vs mild) was analysed. Patients with severe COVID-19 evolution had ... and higher triglycerides. HDL cholesterol and triglyceride concentrations were correlated ...

    Abstract Lipids are indispensable in the SARS-CoV-2 infection process. The clinical significance of plasma lipid profile during COVID-19 has not been rigorously evaluated. We aim to ascertain the association of the plasma lipid profile with SARS-CoV-2 infection clinical evolution. Observational cross-sectional study including 1411 hospitalized patients with COVID-19 and an available standard lipid profile prior (n: 1305) or during hospitalization (n: 297). The usefulness of serum total, LDL, non-HDL and HDL cholesterol to predict the COVID-19 prognosis (severe vs mild) was analysed. Patients with severe COVID-19 evolution had lower HDL cholesterol and higher triglyceride levels before the infection. The lipid profile measured during hospitalization also showed that a severe outcome was associated with lower HDL cholesterol levels and higher triglycerides. HDL cholesterol and triglyceride concentrations were correlated with ferritin and D-dimer levels but not with CRP levels. The presence of atherogenic dyslipidaemia during the infection was strongly and independently associated with a worse COVID-19 infection prognosis. The low HDL cholesterol and high triglyceride concentrations measured before or during hospitalization are strong predictors of a severe course of the disease. The lipid profile should be considered as a sensitive marker of inflammation and should be measured in patients with COVID-19.
    MeSH term(s) Aged ; COVID-19/blood ; COVID-19/etiology ; Cholesterol, HDL/blood ; Female ; Ferritins/blood ; Fibrin Fibrinogen Degradation Products/analysis ; Hospitalization ; Humans ; Lipids/blood ; Male ; Middle Aged ; Severity of Illness Index ; Triglycerides/blood
    Chemical Substances Cholesterol, HDL ; Fibrin Fibrinogen Degradation Products ; Lipids ; Triglycerides ; fibrin fragment D ; Ferritins (9007-73-2)
    Language English
    Publishing date 2021-03-30
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-021-86747-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Low HDL and high triglycerides predict COVID-19 severity

    Lluís Masana / Eudald Correig / Daiana Ibarretxe / Eva Anoro / Juan Antonio Arroyo / Carlos Jericó / Carolina Guerrero / Marcel·la Miret / Silvia Näf / Anna Pardo / Verónica Perea / Rosa Pérez-Bernalte / Núria Plana / Rafael Ramírez-Montesinos / Meritxell Royuela / Cristina Soler / Maria Urquizu-Padilla / Alberto Zamora / Juan Pedro-Botet /
    the STACOV-XULA research group

    Scientific Reports, Vol 11, Iss 1, Pp 1-

    2021  Volume 9

    Abstract: ... the infection was strongly and independently associated with a worse COVID-19 infection prognosis. The low HDL ... cholesterol to predict the COVID-19 prognosis (severe vs mild) was analysed. Patients with severe COVID-19 ... levels and higher triglycerides. HDL cholesterol and triglyceride concentrations were correlated ...

    Abstract Abstract Lipids are indispensable in the SARS-CoV-2 infection process. The clinical significance of plasma lipid profile during COVID-19 has not been rigorously evaluated. We aim to ascertain the association of the plasma lipid profile with SARS-CoV-2 infection clinical evolution. Observational cross-sectional study including 1411 hospitalized patients with COVID-19 and an available standard lipid profile prior (n: 1305) or during hospitalization (n: 297). The usefulness of serum total, LDL, non-HDL and HDL cholesterol to predict the COVID-19 prognosis (severe vs mild) was analysed. Patients with severe COVID-19 evolution had lower HDL cholesterol and higher triglyceride levels before the infection. The lipid profile measured during hospitalization also showed that a severe outcome was associated with lower HDL cholesterol levels and higher triglycerides. HDL cholesterol and triglyceride concentrations were correlated with ferritin and D-dimer levels but not with CRP levels. The presence of atherogenic dyslipidaemia during the infection was strongly and independently associated with a worse COVID-19 infection prognosis. The low HDL cholesterol and high triglyceride concentrations measured before or during hospitalization are strong predictors of a severe course of the disease. The lipid profile should be considered as a sensitive marker of inflammation and should be measured in patients with COVID-19.
    Keywords Medicine ; R ; Science ; Q
    Subject code 616
    Language English
    Publishing date 2021-03-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: Plasma lipid profile: a predictive marker of disease severity among COVID-19 patients-an opportunity for low-income countries.

    Mosaad, Yasser O / Baraka, Mohamed A / Warda, Ahmed E Abou / Ateyya, Hayam / Hussein, Mohammed A / Gaber, Sayed

    Drugs & therapy perspectives : for rational drug selection and use

    2022  Volume 38, Issue 6, Page(s) 286–291

    Abstract: ... of inflammation and risk stratification in patients with COVID-19. Especially in middle- or low-income countries ... lipid profile levels in mild and severe COVID-19 patients.: Method: This was a prospective ... including total cholesterol, triacylglycerols, low-density lipoprotein cholesterol (LDL-C), and high-density ...

    Abstract Objective: This study aimed to assess the correlation between body mass index (BMI) and plasma lipid profile levels in mild and severe COVID-19 patients.
    Method: This was a prospective, observational, cohort study, conducted in a medical referral center specializing in management of COVID-19 cases. Patients were divided into two groups according to infection severity (mild and severe). Blood samples were obtained from all patients who tested positive to a PCR test for measuring biochemical and inflammatory markers such as lactate dehydrogenase, ferritin, C-reactive protein, and d-dimer, as well as lipid profile, including total cholesterol, triacylglycerols, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C), which were analyzed and compared between the two groups. Pearson's correlation was used to assess the correlation between BMI and plasma lipid profile among mild and severe cases.
    Results: The levels of plasma triacylglycerols, d-dimer, lactate dehydrogenase, ferritin, and C-reactive protein with severe infection were significantly different between patients with mild and severe COVID-19 symptoms (
    Conclusion: A routine lipid profile test might help as a marker of inflammation and risk stratification in patients with COVID-19. Especially in middle- or low-income countries, the test can rapidly help clinicians to delineate prognostic measures and hence management and treatment plans for this disease as the levels of the lipid profile were correlated with the patients' BMI and infection severity.
    Language English
    Publishing date 2022-06-27
    Publishing country New Zealand
    Document type Journal Article
    ZDB-ID 1197107-1
    ISSN 1179-1977 ; 1172-0360
    ISSN (online) 1179-1977
    ISSN 1172-0360
    DOI 10.1007/s40267-022-00916-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top